Simon Gayther, PhD, professor of medicine in the Division of Hematology and Oncology in the Joe R. and Teresa Lozano Long School of Medicine and founding director in the school’s Center for Inherited Oncogenesis at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), received a $500,000 UT System […]

  Approximately 30% of individuals with myeloid malignancy diseases have a mutation in a certain gene called tet methylcytosine dioxygenase 2 (TET2). This gene is responsible for providing instructions on creating certain proteins and is known to have a tumor-suppressive function. A study published October 2 in Nature is the first to explain the pathway […]

  Female cancer patients at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, have a new option to preserve their fertility before undergoing treatment. “It is extremely common that cancer patients will experience the loss of fertility and early menopause after gonadotoxic therapies required for many cancer patients,” said […]

Mays Cancer Center offers a survivorship program to patients to prevent cancer from reoccurring through interventions and surveillance to help them live well after treatment.

Learn about Mays Cancer Center’s cardio-oncology program and what cancer patients who have cardiovascular conditions can expect.

Kate Lathrop, MD, shares how participating in a clinical trial can play a key role in an expansion of your care team and survivorship.

Listen to one expert highlight the benefits of having a cancer rehabilitation program that focuses on preventing long-term complications that may come from symptoms or side effects related to cancer treatment.

Executive Director Ruben Mesa, MD, explains the benefits of having access to clinical trials and the cutting-edge capabilities they provide for patients in South Texas.

Mark Bonnen, MD, discusses how Mays Cancer Center’s Medical Management Program integrates primary care into cancer care to better support our patients.

Kate Lathrop, MD, explains the advantages of being able to collaborate as an NCI- designated Cancer Center and produce translational research to improve patient care.